2-(substituted-phenyl)amino-imidazoline derivatives

摘要

This invention relates to IP receptor antagonists selected from the group of compounds represented by Formula I:where:R1 is a group represented by formula (A), (B) or (C);and other substituents as defined in the specification, and their pharmaceutically acceptable salts or crystal forms thereof; and pharmaceutical compositions containing them; and methods for their use as therapeutic agents.